Experience

Venatorx Pharmaceuticals, Inc.
• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee
• Senior Director, Pharmaceutical Development

  • Aug 2018 - Present


Millersville University

• United States
• Fundraising

• Adjunct Professor of Chemistry

  • Jan 2007 - Present

  My responsibilities include teaching courses in general, organic, biochemistry and polymer chemistry. My responsibilities include teaching courses in general, organic, biochemistry and polymer chemistry.



Teva Pharmaceuticals

• Israel
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Director Formulation Development and Drug Delivery Technologies

  • Sep 2004 - Aug 2018

  • Managed a group of Scientist's in the formulation development department for Teva's Global Branded Products Division. • Serve as CMC Leader, representing the CMC function on the cross-functional project team for the development of pharmaceutical products. • Formulate API candidates from drug discovery (pre-IND), through clinical trials and support them into commercialization (post-NDA). • Transfer formulations and develop match records for clinical manufacturing for projects. • Author Form Dev sections of CMC sections of IND and NDA filings, document all relevant IP, as well as all scientific reporting of results for projects. Formulation Experience Includes: • Self-Emulsifying Drug Delivery (SEDDS) capsule formulations for poorly soluble compounds, greatly increasing relative BA. • Microemulsion based capsule formulation for oral delivery of poorly soluble API. • Designed and implemented DoE-based forced degradation program to identify compound's oxidation pathway, resulting in development of rapid screening method to identify a better antioxidant system. • Developed nanoparticulate delivery platform to extend the half-life of plasma labile API to allow for targeting solid tumors. • Developed several novel delivery systems involving formation of nanoparticles from several bio-compatible polymers including PLA, PLGA, PEG-PLA and in situ interfacial polymerization systems. • Developed lyophilized formulations for several parenteral formulations of nanoparticles. • Formulated an XR (24 hour) solid dosage form based on polymeric excipients for line extension. • Experience with transdermal delivery systems



The Dow Chemical Company

• Germany
• Chemical Manufacturing
• 1 - 100 Employee

• Formulation Chemist

  • Sep 2001 - Sep 2004

  • Served as formulator and functional specialist within new business, leveraging interfacial science and advanced emulsion technology to various industries, including: personal care, home care, and pharmaceuticals. • Experienced in water-based formulations containing UV-Inhibitors, polymers, natural products, API, silicones, resins, fragrances, inorganics, biocides and water soluble polymeric thickeners. • Supported new products through scale-up in pilot plant and manufacturing. • Served as Project Manager on large multi-product R&D projects between large corporations. • Completed training in project leadership, facilitation and Six-Sigma methodology.